Company Overview and News


Add ALONC
to your dashboard

Headline News

Pancreatic Cancer Pipeline 2016 Market Report of 282 Companies

2016-08-02 prnewswire
ReportnReports.com adds "Pancreatic Cancer - Pipeline Review, H1 2016" market research report providing comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pancreatic Cancer and special features on late-stage and discontinued projects.

Parkinson's Disease Pipeline Report Covering 179 Companies

2016-08-01 prnewswire
ReportnReports.com adds "Parkinson's Disease - Pipeline Review, H1 2016" market research report that provides an overview of the Parkinson's Disease's therapeutic pipeline with comprehensive information on the therapeutic development complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Gastritis Pipeline Landscape and Therapeutics Market Review 2016

2016-07-29 prnewswire
ReportnReports.com adds "Gastritis - Pipeline Review, H1 2016" market research report complete with comparative analysis at various stages, gastritis therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastritis and special features on late-stage and discontinued projects.

Pipeline of Melasma (Chlosma) Market 2016 Global Review Research

2016-06-28 prnewswire
RnRMarketResearch.com adds "Melasma (Chlosma) - Pipeline Review, H1 2016" to its store. The report provides an overview of the Melasma's (Chlosma) therapeutic pipeline with comprehensive information on the therapeutic development for Melasma (Chlosma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.